+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
UCB (Union chimique belge) - logo

UCB is a global biopharmaceutical company that focuses on neurology and immunology. The company’s core products are Cimzia, Vimpat, Neupro, Keppra and Briviact, and they are also preparing the launch of a potential medicine to help patients with osteoporosis. It offers products for the treatment of central nervous system disorders, allergy and respiratory diseases, and immune and inflammatory disorders. UCB employs over 7,000 people and is based in Brussels, Belgium.

Crohn's Disease Therapeutics Market - Global Forecast 2025-2032 - Product Thumbnail Image

Crohn's Disease Therapeutics Market - Global Forecast 2025-2032

  • Report
  • November 2025
  • 186 Pages
  • Global
From
Anti-Rheumatics Market - Global Forecast 2025-2032 - Product Thumbnail Image

Anti-Rheumatics Market - Global Forecast 2025-2032

  • Report
  • November 2025
  • 187 Pages
  • Global
From
TNF Inhibitors Market - Global Forecast 2025-2032 - Product Thumbnail Image

TNF Inhibitors Market - Global Forecast 2025-2032

  • Report
  • November 2025
  • 192 Pages
  • Global
From
Autoimmune Disease Therapeutics Market - Global Forecast 2025-2032 - Product Thumbnail Image

Autoimmune Disease Therapeutics Market - Global Forecast 2025-2032

  • Report
  • November 2025
  • 181 Pages
  • Global
From
Parkinson's Disease Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update - Product Thumbnail Image

Parkinson's Disease Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update

  • Report
  • February 2023
  • 1359 Pages
  • Global
From
Alpha Synuclein (Non A Beta Component Of AD Amyloid or Non A4 Component Of Amyloid Precursor or NACP or SNCA) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Alpha Synuclein (Non A Beta Component Of AD Amyloid or Non A4 Component Of Amyloid Precursor or NACP or SNCA) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 159 Pages
  • Global
From
Progressive Supranuclear Palsy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Progressive Supranuclear Palsy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 85 Pages
  • Global
From
Krabbe Disease Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Krabbe Disease Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • May 2023
  • 99 Pages
  • Global
From
Restless Legs Syndrome Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - Product Thumbnail Image

Restless Legs Syndrome Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

  • Report
  • November 2022
  • 205 Pages
  • Global
From
Next Generation Immune Checkpoint Inhibitors and Stimulators Market, 2020-2030 - Product Thumbnail Image

Next Generation Immune Checkpoint Inhibitors and Stimulators Market, 2020-2030

  • Report
  • February 2020
  • 360 Pages
  • Global
From
Nucleic Acid Based Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Thumbnail Image

Nucleic Acid Based Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • May 2025
  • 166 Pages
  • Global
From
Restless Legs Syndrome - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Thumbnail Image

Restless Legs Syndrome - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • May 2025
  • 136 Pages
  • Global
From
Neurodegenerative Disease Treatment Market Report by Indication, Drug Type, Route of Administration, Distribution Channel, and Region 2025-2033 - Product Thumbnail Image

Neurodegenerative Disease Treatment Market Report by Indication, Drug Type, Route of Administration, Distribution Channel, and Region 2025-2033

  • Report
  • August 2025
  • 146 Pages
  • Global
From
Crohn's Disease (CD) Treatment Market Report 2025 - Product Thumbnail Image

Crohn's Disease (CD) Treatment Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Epidural Abscess Treatment Market Report 2025 - Product Thumbnail Image

Epidural Abscess Treatment Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Myasthenia Gravis Treatment Market - Global Forecast 2025-2032 - Product Thumbnail Image

Myasthenia Gravis Treatment Market - Global Forecast 2025-2032

  • Report
  • November 2025
  • 187 Pages
  • Global
From
Lewy Body Dementia Treatment Market - Global Forecast 2025-2032 - Product Thumbnail Image

Lewy Body Dementia Treatment Market - Global Forecast 2025-2032

  • Report
  • November 2025
  • 184 Pages
  • Global
From
Childhood Absence Epilepsy Treatment Market - Global Forecast 2025-2032 - Product Thumbnail Image

Childhood Absence Epilepsy Treatment Market - Global Forecast 2025-2032

  • Report
  • November 2025
  • 185 Pages
  • Global
From
Lennox-Gastaut Syndrome Treatment Market - Global Forecast 2025-2032 - Product Thumbnail Image

Lennox-Gastaut Syndrome Treatment Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 189 Pages
  • Global
From
Neurodegenerative Diseases Market - Global Forecast 2025-2032 - Product Thumbnail Image

Neurodegenerative Diseases Market - Global Forecast 2025-2032

  • Report
  • November 2025
  • 183 Pages
  • Global
From
Loading Indicator